Arden R Barry1. 1. Lower Mainland Pharmacy Services, Chilliwack, and the Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia.
Abstract
BACKGROUND: Increasing demand for ambulatory health care services has led to the development of primary care multidisciplinary teams that include pharmacists. The objective of this study was to characterize referrals to a pharmacist in a primary care clinic (PCC) based in Chilliwack, British Columbia. METHODS: This prospective cross-sectional study included all patients referred to the PCC pharmacist over 12 months (May 2015 to April 2016). Data regarding the source/reason for referral, patient demographics, medical problems/medications and number/category of identified drug therapy concerns (DTCs) were collected. RESULTS: A total of 137 referrals were received. Mean age was 60 years and 59% were female. Twenty patients (15%) did not attend their appointment. Fifty-eight percent were new clinic patients identified using a Medication Risk Assessment Questionnaire (MRAQ), 30% were from PCC clinicians and 12% were from community family physicians. The most common reason for referral was for a medication review (82%). Median number of medical problems and medications per patient were 7 (interquartile range [IQR] 5) and 11 (IQR 7.5), respectively. A total of 460 DTCs were identified (median 4 per patient, IQR 3.5), of which 34% were medication without an indication and 28% an untreated indication. DISCUSSION AND CONCLUSION: The most common source of referrals to a PCC pharmacist was for medication reviews of new patients using an MRAQ. Most referred patients had multiple medical problems and polypharmacy, and few were referred for disease-specific management. The number of DTCs per patient was variable and, despite polypharmacy being commonplace, almost one-third of patients had an untreated indication.
BACKGROUND: Increasing demand for ambulatory health care services has led to the development of primary care multidisciplinary teams that include pharmacists. The objective of this study was to characterize referrals to a pharmacist in a primary care clinic (PCC) based in Chilliwack, British Columbia. METHODS: This prospective cross-sectional study included all patients referred to the PCC pharmacist over 12 months (May 2015 to April 2016). Data regarding the source/reason for referral, patient demographics, medical problems/medications and number/category of identified drug therapy concerns (DTCs) were collected. RESULTS: A total of 137 referrals were received. Mean age was 60 years and 59% were female. Twenty patients (15%) did not attend their appointment. Fifty-eight percent were new clinic patients identified using a Medication Risk Assessment Questionnaire (MRAQ), 30% were from PCC clinicians and 12% were from community family physicians. The most common reason for referral was for a medication review (82%). Median number of medical problems and medications per patient were 7 (interquartile range [IQR] 5) and 11 (IQR 7.5), respectively. A total of 460 DTCs were identified (median 4 per patient, IQR 3.5), of which 34% were medication without an indication and 28% an untreated indication. DISCUSSION AND CONCLUSION: The most common source of referrals to a PCC pharmacist was for medication reviews of new patients using an MRAQ. Most referred patients had multiple medical problems and polypharmacy, and few were referred for disease-specific management. The number of DTCs per patient was variable and, despite polypharmacy being commonplace, almost one-third of patients had an untreated indication.
Authors: Richard Lowrie; Frances S Mair; Nicola Greenlaw; Paul Forsyth; Pardeep S Jhund; Alex McConnachie; Brian Rae; John J V McMurray Journal: Eur Heart J Date: 2011-11-14 Impact factor: 29.983
Authors: Phayom Sookaneknun; Robert M E Richards; Jaratbhan Sanguansermsri; Chai Teerasut Journal: Ann Pharmacother Date: 2004-11-02 Impact factor: 3.154
Authors: N N Ladhani; S R Majumdar; J A Johnson; R T Tsuyuki; R Z Lewanczuk; R Spooner; S H Simpson Journal: Diabet Med Date: 2012-11 Impact factor: 4.359
Authors: Fizza Gilani; Sumit R Majumdar; Jeffrey A Johnson; Ross T Tsuyuki; Richard Z Lewanczuk; Richard Spooner; Scot H Simpson Journal: Ann Pharmacother Date: 2013-01-16 Impact factor: 3.154
Authors: Kevin Pottie; Barbara Farrell; Susan Haydt; Lisa Dolovich; Connie Sellors; Natalie Kennie; William Hogg; Carmel M Martin Journal: Can Fam Physician Date: 2008-12 Impact factor: 3.275
Authors: Shubha Bhat; Miranda Kroehl; Whitley M Yi; Jaclyn Jaeger; Angela M Thompson; H Mindy Lam; Danielle Loeb; Katy E Trinkley Journal: J Am Pharm Assoc (2003) Date: 2019-04-01